Friday, January 30, 2026

Over 1 Million Sold—Now Cadillac’s Escalade Gets a Major Makeover

Cadillac unveils THE NEW ESCALADE in South Korea, featuring advanced updates and a redesign, celebrating over 1 million global sales.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

National Pension Debate: Will South Korea Finally Reach a Consensus?

South Korea's ruling party, opposition, and government will meet Thursday to discuss key issues in National Pension reform.

Tag: drugs

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

As Wegovy and Mounjaro Soar, Korean Biotechs Seek a Slice of the Obesity Drug Market

South Korean firms are innovating in the GLP-1 obesity treatment market, developing unique drugs to compete with industry leaders.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

High on Gummies: The New Disturbing Marijuana Trend

The police arrested several people after ingesting gummies with cannabis components and reporting symptoms of dizziness to 119, the Korean Emergency Service. On the 12th,...

Top News

- Our Sponsors Ad -

Follow us